Cronograma de promoção Cipla Limited
Sobre a empresa Cipla Limited
Cipla Limited вместе со своими дочерними компаниями производит и продает фармацевтическую продукцию в Индии, США, Южной Африке и за рубежом. Компания предлагает активные фармацевтические ингредиенты; и составы в различных терапевтических областях, таких как ИМ, стенокардия, сердечная недостаточность, гипертония, аритмия, нарушения липидов и диабет, ожирение, ВИЧ, респираторные заболевания, урология, онкология, кардиометаболизм, здоровье детей, инфекционные заболевания и реанимация, гепатит, женское здоровье, офтальмология и нейропсихиатрия. mais detalhesISIN | INE059A01026 |
---|---|
Industry | Pharmaceuticals |
Sector | Health Care |
Валюта | inr |
Валюта отчета | inr |
Див.доход ао | 1.39 |
Дивиденд ао | 13 |
Сайт | https://www.cipla.com |
Цена ао | 1461.9 |
Alteração de preço por dia: | -0.1265% (1461.9) |
---|---|
Alteração de preço por semana: | +0.072% (1459) |
Alteração de preço por mês: | +0.596% (1451.4) |
Alteração de preço em 3 meses: | +0.7278% (1449.5) |
Mudança de preço em seis meses: | -12.1% (1661) |
Mudança de preço por ano: | -1.52% (1482.6) |
Mudança de preço em 3 anos: | +38.89% (1051.2) |
Mudança de preço em 5 anos: | +227.74% (445.49) |
Mudança de preço em 10 anos: | 0% (1460.05) |
Mudança de preço desde o início do ano: | -0.6769% (1470) |
|
Subestimação
|
Eficiência
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Obrigação
|
Impulso de crescimento
|
Instituições | Volume | Compartilhar, % |
---|---|---|
Vanguard International Stock Index-Emerging Markets Stk | 7209048 | 0.89 |
Vanguard International Stock Index-Total Intl Stock Indx | 6629962 | 0.82 |
Advisors Inner Circle Fund III-GQG Partners Emerging Markets Equity Fd | 5032866 | 0.62 |
iShares Core MSCI Emerging Markets ETF | 4328274 | 0.54 |
Hartford/Schroders Emerging Markets Equity Fd | 3016357 | 0.37 |
iShares MSCI Emerging Markets ETF | 1961337 | 0.24 |
DFA Emerging Markets Core Equity Portfolio | 1598801 | 0.2 |
Fidelity SAI Emerging Markets Low Volatility Index Fund | 1430891 | 0.18 |
Mercer Emerging Markets Equity Fd | 1178896 | 0.15 |
Driehaus Emerging Markets Growth Fund | 1127122 | 0.14 |
Fidelity SAI Emerging Markets Value Index Fund | 1063438 | 0.13 |
Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 969506 | 0.12 |
DFA Investment Dimensions-DFA Emerging Mkts Value | 896605 | 0.11 |
DFA Emerging Markets Series | 657406 | 0.08 |
Supervisor | Cargo | Pagamento | Ano de nascimento |
---|---|---|---|
Dr. Raju Sunil Mistry M.A., Ph.D. | President & Global Chief People Officer | N/A | 1965 (60 anos) |
Mr. Pradeep Bhadauria | President & Global Chief Scientific Officer | N/A | |
Mr. Ashish Adukia | Global Chief Financial Officer | N/A | |
Mr. Dinesh Ramniranjan Jain | Senior VP & Head of Corporate Finance | N/A | |
Mr. Naveen Bansal | Head of Investor Relations | N/A | |
Mr. Rajendra Kumar Chopra | Compliance Officer & Company Secretary | 15.3M | |
Ms. Heena Kanal | Senior Vice-President of Corporate Communications | N/A | |
Mr. Umang Vohra B.E., M.B.A. | MD, Global CEO & Executive Director | 1971 (54 ano) | |
Ms. Sneha Hiranandani B Com | Chief Information Officer | ||
Dr. Jaideep A. Gogtay M.D., Ph.D. | Global Chief Medical Officer | 1967 (58 anos) |
Endereço: India, Mumbai, Cipla House - abrir no Google Maps, abrir mapas Yandex
Site: https://www.cipla.com
Site: https://www.cipla.com